Lymphoma-based therapy for refractory or relapsed Epstein–Barr virus–related hemophagocytic lymphohistiocytosis in children

Lymphoma-based therapy for refractory or relapsed Epstein–Barr virus–related hemophagocytic lymphohistiocytosis in children

Epstein–Barr virus–related hemophagocytic lymphohistiocytosis (EBV-HLH) is a life-threatening hyperinflammatory syndrome. Although etoposide-based immunochemotherapy has improved survival rates, consensus regarding the appropriate salvage therapy for patients with refractory or relapsed EBV-HLH is l...

Full description

Bibliographic Details
Main Authors: Chao-Neng Cheng, Wei-Ying Chu, Kung-Chao Chang, Jiann-Shiuh Chen
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Journal of the Formosan Medical Association
Subjects:
Epstein–Barr virus
Hemophagocytic lympho-histiocytosis
Refractory
Relapse
T-cell lymphoma
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664622000092

Internet

http://www.sciencedirect.com/science/article/pii/S0929664622000092

Similar Items